Alex Dean, MPH

Veradigm

Disclosure(s): Veradigm: Employee of Veradigm, which received a research contract to conduct this study with and on behalf of CSL Seqirus

Poster(s):

• (P-626) Relative Vaccine Effectiveness of Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines Against Test-Confirmed Influenza in the United States 2022-23 Influenza Season
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT